SCIENTIFIC HUB

Follow the evidence.

SCIENTIFIC LITERATURE · MED

Glucocerebrosidase rescues alpha-synuclein from amyloid formation in vitro.

J Mol Biol · 2026-07-21

DOI: 10.1016/j.jmb.2026.169954PMID: 42480764

Check source for accessJournal ArticleOriginal source ↗

Research overview

The text below is the source article’s original abstract under a verified reuse license. cc by

Alpha-synuclein (αSyn) is a lipid-binding protein that assembles into amyloid fibrils in Parkinson's disease (PD). Lipid binding can accelerate the rate of αSyn fibril formation by stimulating primary nucleation. Recently, the lysosomal protein glucocerebrosidase (GCase) has been identified as a major risk factor in both genetic and sporadic PD. Using solution-state nuclear magnetic resonance spectroscopy, we observe that GCase binds to the C-terminal region of αSyn and attenuates the lipid-binding affinity of αSyn. Mechanistically, this interaction model involves competition between lipids and GCase for αSyn, with lipids and GCase preferentially interacting with the N- and C-terminal regions respectively, in a tug-of-war mechanism. Moreover, the addition of GCase to mature αSyn fibrils increases the NMR-visible population of flexible αSyn, indicating altered fibril-associated αSyn dynamics. Our findings provide a mechanistic explanation for the observed links between changes in GCase abundance and PD.

Scientific assessment

01

Research question

Assess the question within the original study’s scope.

02

Methods & sample

Check the source article for study design and sample details.

03

Key findings

An editorially approved findings summary is not yet published for this record.

04

Limitations

Generalizability, bias and clinical meaning require separate assessment.

Methods, samples and clinical conclusions are not inferred from bibliographic metadata.